News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
國藥太極在研生物藥「司美格魯肽」開啟全球招商
太極集團(600129.SH)表示,國藥太極攜核心在研生物藥「司美格魯肽」亮相廣交會,並正式開啟全球招商。國藥太極目前已按中美GMP要求,建成原料藥與制劑生產車間。該藥品原料已完成美國DMF備案,具成熟全球供應能力。(ta/da)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
國藥太極在研生物藥「司美格魯肽」開啟全球招商
Close
Recommend
6
Positive
5
Negative
0
 
 

太極集團(600129.SH)  -0.130 (-0.838%)   表示,國藥太極攜核心在研生物藥「司美格魯肽」亮相廣交會,並正式開啟全球招商。

國藥太極目前已按中美GMP要求,建成原料藥與制劑生產車間。該藥品原料已完成美國DMF備案,具成熟全球供應能力。(ta/da)(A Shares quote is delayed for at least 15 mins.)

AASTOCKS新聞

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.